Showing results (341-350 of 348) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 348 results.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survivalC Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
Journal of Hepatology|May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialCynthia Levy, George F Abouda, Bahri M Bilir, et al.
Hepatology (Baltimore, Md.)|June 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled studyGideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein, et al.
JHEP Reports : Innovation in Hepatology|October 9, 2024
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitisSurain B Roberts, Woo Jin Choi, Lawrence Worobetz, et al.
Gastroenterology|March 10, 2017
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing CholangitisTobias J Weismüller, Palak J Trivedi, Annika Bergquist, et al.
Pageof 35